Aurenar
PrivateLast Round
Seed
Jul 28, 2026
Total Funding Raised
$5.7M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Aurenar is a medical device company that develops a non-invasive, single-use neuromodulation platform designed to reduce life-threatening complications in intensive care unit patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aurenar Comparables
Compare Aurenar with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evren Technologies | 65% | |
| Spark Biomedical Inc | 62% | |
| Surf Therapeutics | 61% |
Aurenar Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 28, 2026 |
Key People
Founding team and executive leadership
Aurenar Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kaleida Capital | Seed |
| Solas BioVentures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 1262% MoM, reaching 1.4K.
- Aug 16, 2026
Grew 30% QoQ from 10 to 13 employees.
Recent news
Latest coverage and updates
- is_developingSep 21, 2026
Aurenar is developing neuromodulation device aimed specifically at stroke recovery on Sep 21st '26.
- receives_financingJul 28, 2026
Aurenar received financing of $5.7M in Seed on Jul 28th '26.
- is_developingJul 2, 2026
Aurenar is developing V-Link.
- recognized_asJul 1, 2026
Aurenar recognized as FDA Breakthrough Device designation on Jul 1st '26.
Aurenar Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aurenar's valuation, stock price, and market status.
Is Aurenar a public or private company?
Aurenar is a private company.
What is the current stock price of Aurenar?
Aurenar is a private company with no public stock price. Caplight tracks Aurenar's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Aurenar worth (valuation)?
Valuation information for Aurenar is not publicly available.
Can I buy Aurenar stock?
Aurenar shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aurenar's last funding round?
Aurenar's most recent funding round was Seed on July 28, 2026.
Who are the main investors in Aurenar?
Key investors in Aurenar include Solas BioVentures.
Will Aurenar IPO soon?
No public IPO plans have been announced for Aurenar.
How can I track Aurenar secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aurenar's secondary market activity and sign up for updates.